GLUL and cancer: Our in vitro data are confirmed in several mouse models of cancer, in which glufosinate treatment significantly reduces metastasis formation and promotes a phenotype switch of TAMs toward a M1‐like state, similarly to what observed in the conditional, macrophage‐specific, GS knockout mouse (Palmieri et al, 2017b).